Advanced search
Publication Cover
Acta Oncologica Volume 56, 2017 - Issue 7
Journal homepage
1,488
Views
9
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR

Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patients

J. J. M. KwakmanDepartment of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Correspondence[email protected]
,
A. BaarsDepartment of Medical Oncology, Hospital Gelderse Vallei, Ede, The Netherlands;
,
H. BootDepartment of Gastroenterology and Hepatology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;
,
J. F. M. PruijtDepartment of Medical Oncology, Jeroen Bosch Hospital, Den Bosch, The Netherlands;
,
S. B. WintherDepartment of Medical Oncology, Odense University Hospital, Odense, Denmark
,
P. PfeifferDepartment of Medical Oncology, Odense University Hospital, Odense, Denmark
&
C. J. A. PuntDepartment of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands;
show all
Pages 1023-1026 | Received 28 Nov 2016, Accepted 28 Dec 2016, Published online: 19 Jan 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patients
Source: Figshare
Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patients
Source: Figshare

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.